Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | ACE | P12821 | 2/20 | 0.33 |
| ▸ | PEPD | P12955 | 1/20 | 0.33 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 5/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7642427 | 0.84 | KMT2A (0.40) | KCNK3KMT2AL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL7643460 | 0.78 | ACE (0.42) | KCNK3KMT2AL3MBTL1ACEPEPD | |
| SCHEMBL7644416 | 0.77 | KMT2A (0.47) | KMT2AL3MBTL1ACE | |
| SCHEMBL7644425 | 0.75 | PEPD (0.38) | KCNK3KMT2AL3MBTL1TSHRPEPD | |
| SCHEMBL7445316 | 0.75 | SLC6A3 (0.40) | KMT2AALDH1A1CYP3A4TSHRSLC6A3 | |
| SCHEMBL7401906 | 0.72 | SLC6A3 (0.36) | KMT2AALDH1A1CYP3A4SLC6A3PTGER4 | |
| SCHEMBL7404464 | 0.70 | KMT2A (0.43) | KMT2AL3MBTL1ACEPEPDRAB9A | |
| SCHEMBL7404462 | 0.70 | KMT2A (0.43) | KMT2AL3MBTL1ACEPEPDRAB9A | |
| SCHEMBL7639713 | 0.70 | KMT2A (0.47) | KMT2AL3MBTL1ACE | |
| SCHEMBL4781667 | 0.67 | PTGER4 (0.37) | KMT2ACYP3A4TSHRSLC6A3PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6468977-B1 | COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS | APOTEX INC. (CA) | 2002-10-22 | — | — | US | disclosed |
| US-6162791-A | Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes | APOTEX INC. (CA) | 2000-12-19 | — | — | US | disclosed |